Comment: analysis of severe adverse events related to the use of mifepristone as an abortifacient.
Shannon
Caitlin S
CS
D000014:Abnormalities, Drug-Induced / Q000453:epidemiology; D000021:Abortifacient Agents, Steroidal / Q000009:adverse effects*; D000328:Adult; D005260:Female; D006801:Humans; D015735:Mifepristone / Q000009:adverse effects*; D020331:Mobius Syndrome / Q000139:chemically induced; D011247:Pregnancy; D011256:Pregnancy Outcome; D014481:United States / Q000453:epidemiology; D014486:United States Food and Drug Administration
D000021:Abortifacient Agents, Steroidal; D015735:Mifepristone